Constarium
← Search

Data · dataset · 2026

The discovery of a novel peptide identified from the defensive skin secretion of Phyllomedusa hypochondrialis

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.17034/32640129.v1

The process of searching for novel bioactive peptides in South American anurans was initially introduced in Phyllomedusa frogs.

Description

The poisonous skin secretions of this group of frogs are thought to have developed as a result of interactions between predators and prey as well as defense against microbial invasion. These complex mixtures of bioactive peptides are capable of warding off pathogens and prospective predators.

New peptides with homologies to hormones, neurotransmitters, antibiotics, and a number of additional peptides with unclear biological activities are discovered for each newly discovered anuran species. It has been established that several substances have medicinal potential.In this thesis, a novel antimicrobial peptide, named QUB-2000, was isolated and identified in the secretions of the Phyllomedusa hypochondrialis. Via "shotgun" molecular cloning, the biosynthetic precursor sequence of QUB-2000 was obtained.

Read the rest (2 more)

Afterwards, RP-HPLC and MALDI-TOF-MS fragmentation sequencing was employed to double-confirm the primary structure of this novel peptide. The mature peptide was synthesised via solid phase peptide synthesis and subjected to minimal inhibitory concentration (MIC) assay using different micro-organisms and haemolytic activity assay using horse red blood cells. The results obtained from three individual experiments showed that QUB-2000 exhibited broad-spectrum antimicrobial abilities against S. aureus and E. coli with MIC values of 32 μM and 64 μM, respectively.

QUB-2000 had weak antimicrobial activity against Candida albicans with MIC values of 128 μM. QUB-2000 exhibited no inhibitory effect against lung cancer cell line H838. Also, the haemolytic study of this novel peptide was found to be weak, with less than 5% haemolysis at 128 μM. Therefore, the peptide QUB-2000 has the potential to be an antimicrobial candidate.<br><br><i>Thesis is embargoed until 31 December 2029.</i>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Cancer 75% · Sequencing 75%
Provenance · 3 source records, 10 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3264012910 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3264012910 d agoJSON v1
DMU Figshareoai:figshare.com:article/3264012910 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancerenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[modality].local:modality:sequencingenrichment · zivahub uct ac zakeyword-concept-rules@1.0.0title+description (75%)
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title